Quality of Life and Psycological Evaluation of Patients Affected by Head and Neck Cancer
NCT02984033 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-10-24
Summary
The prospective trial is to describe the quality of life and psychological effects in patients with head and neck tumor receiving curative intent treatment
Conditions
- Quality of Life
Interventions
- RADIATION
-
Head and Neck patients
Treatment consists of Intensity Modulated Radiation Therapy (until 2.2 Gy) with a total dose of 50-66 Gy in post-operative setting and 66-72 Gy in radical setting.
Sponsors & Collaborators
-
Michele Tedeschi
lead OTHER
Principal Investigators
-
Ciro Franzese, MD · Humanitas Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-02-01
- Completion
- 2018-02-01
Countries
- Italy
Study Locations
More Related Trials
-
Big Data for Quality of Life in Head and Neck Cancer
NCT05315570 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03815903 ·Status: RECRUITING ·Phase: PHASE3
-
Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
NCT02920216 ·Status: COMPLETED ·Phase: NA
-
Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk
NCT00937612 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT00006051 ·Status: COMPLETED ·Phase: PHASE2
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Effect of Prehabilitation on Head and Neck Cancer Patients
NCT06593639 ·Status: RECRUITING ·Phase: NA
-
Quality of Life in Head and Neck Patients
NCT04853862 ·Status: UNKNOWN
-
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
NCT04611113 ·Status: RECRUITING ·Phase: NA
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma:The POTENTIAL Study
NCT04814069 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
NCT06344208 ·Status: RECRUITING
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
NCT00004094 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00625937 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas
NCT02776163 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
NCT02901483 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT00002951 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer
NCT01126216 ·Status: TERMINATED ·Phase: PHASE3
-
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
NCT00117572 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Comparing Different Follow-up Strategies
NCT05388136 ·Status: TERMINATED ·Phase: NA
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin
NCT00999700 ·Status: UNKNOWN ·Phase: PHASE3
-
Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT03480672 ·Status: COMPLETED ·Phase: PHASE2